Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

Related Articles by Review for PubMed (Select 3109764)

1.

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, et al.

Circulation. 1987 Jul;76(1):142-54.

PMID:
3109764
2.

New developments in thrombolytic therapy.

Collen D, Gold HK.

Adv Exp Med Biol. 1990;281:333-54. Review.

PMID:
2129372
3.
4.

Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator?

Collen D.

Ann Intern Med. 1990 Apr 1;112(7):529-38. Review.

PMID:
2107781
5.

Thrombolytic therapy in acute myocardial infarction.

Rutherford JD, Braunwald E.

Chest. 1990 Apr;97(4 Suppl):136S-145S. Review.

PMID:
2108851
6.

Thrombolytic treatment in acute myocardial infarction.

Verstraete M.

Circulation. 1990 Sep;82(3 Suppl):II96-109. Review.

PMID:
2118432
7.

Designing thrombolytic agents: focus on safety and efficacy.

Collen D.

Am J Cardiol. 1992 Jan 3;69(2):71A-81A. Review.

PMID:
1729881
8.

[New thrombolytic agents in myocardial infarction].

Charbonnier B, Lang M, Brochier M.

Arch Mal Coeur Vaiss. 1987 Nov;80(12):1785-91. Review. French.

PMID:
3128222
9.

Patency trials with reteplase (r-PA): what do they tell us?

Bode C, Nordt TK, Peter K, Smalling RW, Runge MS, K├╝bler W.

Am J Cardiol. 1996 Dec 19;78(12A):16-9. Review.

PMID:
8990406
10.

[t-PA in thrombolytic therapy of acute myocardial infarct].

Rutsch W, Schmutzler H.

Herz. 1994 Dec;19(6):336-52. Review. German.

PMID:
7843690
11.

Thrombolytic therapy in Europe: current status.

Vahanian A.

Eur Heart J. 1996 Sep;17 Suppl E:21-7. Review.

12.

Thrombolytic therapy in acute myocardial infarction: Part II--rt-PA.

Mueller HS, Roberts R, Teichman SL, Sobel BE.

Med Clin North Am. 1989 Mar;73(2):387-407. Review.

PMID:
2493116
13.

Comparison of thrombolytic agents: selected hematologic, vascular and clinical events.

Marder VJ.

Am J Cardiol. 1989 Jul 5;64(2):2A-7A; discussion 24A-26A. Review.

PMID:
2662739
14.

Alteplase: a pharmacoeconomic evaluation of its use in the management of myocardial infarction.

Barradell LB, Goa KL.

Pharmacoeconomics. 1995 Nov;8(5):428-59. Review.

PMID:
10172669
15.

New developments in thrombolytic therapy.

Collen D, Gold HK.

Verh K Acad Geneeskd Belg. 1989;51(3):191-228; discussion 229. Review.

PMID:
2686261
16.

Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction.

Gillis JC, Goa KL.

Pharmacoeconomics. 1996 Sep;10(3):281-310. Review.

PMID:
10163575
17.

Advances in thrombolytic therapy for acute myocardial infarction.

Topol EJ.

J Clin Pharmacol. 1987 Oct;27(10):735-45. Review.

PMID:
3123526
18.

Reperfusion therapy in inferior myocardial infarction.

Bates ER.

J Am Coll Cardiol. 1988 Dec;12(6 Suppl A):44A-51A. Review.

PMID:
3142944
19.

[Thrombolytic treatment in the acute phase of myocardial infarction. Evaluation in 1986].

Kher A, Michel PL, Samama M, Acar J.

Ann Med Interne (Paris). 1986;137(7):584-9. Review. French.

PMID:
3545003
20.

Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.

Battershill PE, Benfield P, Goa KL.

Drugs Aging. 1994 Jan;4(1):63-86. Review.

PMID:
8130384
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk